2022
Regulating Posttrial Access to In-Dwelling Class III Neural Devices
Wright M, Fins J. Regulating Posttrial Access to In-Dwelling Class III Neural Devices. 2022, 256-267. DOI: 10.1017/9781108975452.020.Peer-Reviewed Original ResearchMedical device regulationRegulatory lawsDevice regulationCambridge CorePosttrial accessMedical devicesRegulatory concernsOpen AccessPatient privacyRegulationPublic healthMedical providersLawInnovative productsEUBookConcernsControversiesPrivacyPolicymakersAccessUSStakeholdersCambridgeMultidisciplinary evaluation
2015
Ethics of neuromodulation in psychiatry
Fins J, Pohl B. Ethics of neuromodulation in psychiatry. 2015, 15-26. DOI: 10.1002/9781118801086.ch2.Peer-Reviewed Original ResearchSevere psychiatric illnessHealth care systemNeuropsychiatric conditionsPsychiatric illnessPervasive stigmaMental illnessCare systemDeep brain stimulationBrain stimulationClinical ethicsMoral dilemmasDerivative questionsIllnessEthicsDevice regulationNeuromodulationTranslational researchClinical needPsychiatryStigmaHealthBrainIntervention
2014
Devices, Drugs, and Difference: Deep Brain Stimulation and the Advent of Personalized Medicine
Fins J. Devices, Drugs, and Difference: Deep Brain Stimulation and the Advent of Personalized Medicine. 2014, 607-620. DOI: 10.1007/978-94-007-4707-4_33.Peer-Reviewed Original ResearchFDA humanitarian device exemptionIntellectual property exchangeHumanitarian Device ExemptionPharmaceutical regulationDevice regulationProperty exchangeTherapeutic misconceptionInvestigative realmsPatient-centered needsDeep brain stimulationAdvent of personalized medicinePersonalized medicineObsessive-compulsive disorderRegulationBrain stimulationInterdisciplinary expertiseFace barriersExemptionMolecular therapeuticsConflictInvestigation toolScope